Singapore’s state-owned investment firm Temasek and Chinese internet tycoon Jack Ma-backed Yunfeng Capital have led a $75 million Series B into WuXi NextCODE.

The Abu Dhabi Investment Authority and Singapore’s GIC have bought a minority stake in PPD, valuing the CRO giant at more than $9 billion.

Amid new approvals last year, drugmakers also suffered R&D setbacks, cut research staff, rejigged their operations and refocused their pipelines.

Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

WuXi AppTec is seeking an IPO on China’s common stock market, a move that confirmed buzz that the CRO giant would re-enlist its businesses in three pieces.

Parexel has acquired contract medical affairs services provider The Medical Affairs Company as it looks to bolster its outsourced healthcare specialist…

PPD is opening a 24-bed clinical research unit in Las Vegas in support of its early drug development services.

WuXi AppTec, one of the largest CROs in China, has just acquired a Shanghai-based preclinical counterpart, HD Biosciences, building further on its core…

Financials